Updated
Twelve companies, including several biotechnology firms and D-Wave Quantum, posted Form 8-K current reports to the SEC's EDGAR system between 12:01 and 12:08 UTC on November 10, 2026. The feed listed the filings by filer name and CIK number only, without excerpts describing their contents. The filings cover Hemab Therapeutics, City Therapeutics, Palladyne AI, Cullinan Therapeutics, Sionna Therapeutics, Upstream Bio, Olema Pharmaceuticals, 908 Devices, Humacyte, Ovid Therapeutics, Opus Genetics and D-Wave Quantum. The reports do not describe the events that prompted them, so their significance cannot be assessed from the available coverage.